Home  |   Archive  |   Online Submission  |   News & Events  |   Subscribe  |   APFA  |   Society  |   Contact Us  |   中文版
Search   
 
Journal

Ahead of print
Authors' Accepted
    Manuscripts
new!
Current Issue
Archive
Acknowledgments
Special Issues
Browse by Category

Manuscript Submission

Online Submission
Online Review
Instruction for Authors
Instruction for Reviewers
English Corner new!

About AJA

About AJA
Editorial Board
Contact Us
News

Resources & Services

Advertisement
Subscription
Email alert
Proceedings
Reprints

Download area

Copyright licence
EndNote style file
Manuscript word template
Guidance for AJA figures
    preparation (in English)

Guidance for AJA figures
    preparation (in Chinese)

Proof-reading for the
    authors

AJA Club (in English)
AJA Club (in Chinese)

 
Abstract

Volume 11, Issue 2 (March 2009) 11, 266–271; 10.1038/aja.2008.12

Testosterone alleviates tumor necrosis factor-alpha-mediated tissue factor pathway inhibitor downregulation via suppression of nuclear factor-kappa B in endothelial cells

Hong Jin1, Wen-Bing Qiu1, Yi-Fang Mei2, Dong-Ming Wang1, Yu-Guang Li1 and Xue-Rui Tan1

1 The First Affiliated Hospital of Shantou University Medical College, Shantou 515041, China
2 The First Affiliated Hospital of Harbin Medical University, Harbin 150081, China

Correspondence: Dr Xue-Rui Tan, The First Affiliated Hospital of Shantou University Medical College, Shantou 515041, China. Fax: +86-754-8825-9850 E-mail: Tanxuerui@vip.sina.com

Received 23 June 2008; Revised 3 August 2008; Accepted 21 August 2008; Published online 26 January 2009

Abstract

We have observed earlier that testosterone at physiological concentrations can stimulate tissue factor pathway inhibitor (TFPI) gene expression through the androgen receptor in endothelial cells. This study further investigated the impact of testosterone on TFPI levels in response to inflammatory cytokine tumor necrosis factor-alpha (TNF-α). Cultured human umbilical vein endothelial cells were incubated in the presence or absence of testosterone or TNF-α. TFPI protein and mRNA levels were assessed by enzyme-linked immunosorbent assay and quantitative real-time reverse transcription polymerase chain reaction. To study the cellular mechanism of testosterone's action, nuclear factor-kappa B (NF-κB) translocation was confirmed by electrophoretic mobility shift assays. We found that after NF-κB was activated by TNF-α, TFPI protein levels declined significantly by 37.3% compared with controls (P < 0.001), and the mRNA levels of TFPI also decreased greatly (P < 0.001). A concentration of 30 nmol L-1 testosterone increased the secretion of TFPI compared with the TNF-α-treated group. NF-κB DNA-binding activity was significantly suppressed by testosterone (P < 0.05). This suggests that physiological testosterone concentrations may exert their antithrombotic effects on TFPI expression during inflammation by downregulating NF-κB activity.

Keywords: nuclear factor-kappa B, testosterone, tissue factor pathway inhibitor

PDF | PDF | 中文摘要 |

 
Browse:  3118
 
Asian Journal of Andrology CN 31-1795/R ISSN 1008-682X  Copyright © 2023  Shanghai Materia Medica, Chinese Academy of Sciences.  All rights reserved.